Friday, June 19, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “placebo” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 588
Total indexed 20,548
Sponsors 1,771

Quick answer

Showing 588 pipeline programs matching "placebo" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

588 results for “placebo” Back to intelligence hub

Search results

Page 23 of 25
  1. Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) + Placebo

    Spero Therapeutics

    TQT Study

    phase 1 small molecule completed

    1 trial
  2. Telaprevir; Moxifloxacin; Placebo

    Vertex Pharmaceuticals (Australia) Pty.

    Hepatitis C

    phase 1 small molecule completed

    1 trial
  3. Tolvaptan 15mg or 30mg or 60mg or Placebo

    Otsuka Beijing Research Institute

    Healthy

    phase 1 small molecule completed

    1 trial
  4. VX-985 or matching placebo

    Vertex Pharmaceuticals (Australia) Pty.

    Chronic Hepatitis C

    phase 1 small molecule completed

    1 trial
  5. Varenicline, then placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine Addiction

    phase 1 small molecule completed

    1 trial
  6. placebo

    Innovent Biologics (Suzhou) Co.

    Healthy

    phase 1 mab completed

    1 trial
  7. placebo

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial
  8. placebo control

    Takeda

    Hemophilia

    phase 1 small molecule terminated

    1 trial
  9. sulfamethoxazole + MMX placebo

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial
  10. ATORVASTATIN, PLACEBO

    Disc Medicine

    Atherosclerosis

    approved small molecule active

    1 trial
  11. Alirocumab, Placebo product for REGN727

    The George Institute

    Cardiac allograft vaculopathy in recent heart transplant recipients

    approved small molecule active

    1 trial
  12. D-CURE 25000 UI gélules., Placebo of vitamin D

    Laboratoire HRA Pharma

    Periodontitis

    approved small molecule active

    1 trial
  13. Entecavir + Placebo

    ShuGuang Hospital

    Liver Cirrhosis Due to Hepatitis B Virus

    approved small molecule active

    1 trial
  14. LABA/LAMA or Placebo inhalation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Bronchiectasis Adult

    approved small molecule active

    1 trial
  15. Naltrexone HCl/Bupropion HCl Placebo

    Takeda

    Weight Regain Post Bariatric Surgery

    approved small molecule terminated

    1 trial
  16. PLACEBO, ISMIGEN tabletki podjezykowe

    Lacuna Pharma Pty Ltd

    Respiratory Tract Infections

    approved small molecule active

    1 trial
  17. Pioglitazone then Placebo

    Takeda

    Diabetes

    approved small molecule completed

    1 trial
  18. Placebo

    Jazz Pharmaceuticals Ireland Limited

    Chronic Fatigue Syndrome

    approved small molecule terminated

    1 trial
  19. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Dependence

    approved small molecule completed

    1 trial
  20. Placebo

    Takeda

    Chronic Insomnia

    approved small molecule terminated

    1 trial
  21. Placebo

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Gastroesophageal Reflux Disease

    approved other active

    1 trial
  22. Placebo

    Takeda

    Post-Traumatic Stress Disorder

    approved small molecule completed

    1 trial
  23. Placebo for Allergy

    A. Menarini Industrie Farmaceutiche Riunite s.r.l.

    Allergy

    approved small molecule active

    1 trial
  24. Placebo of rosuvastatin (tablet) as produced...

    Disc Medicine

    Statin-intolerance, High cardiovascular risk (previous cardiovascular disease or familial hypercholesterolemia)

    approved small molecule active

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.